The conference witnessed an overwhelming response, bringing together over 700 attendees, including 150 distinguished speakers, 12 key sponsors, an ...

Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.

The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...

* Q3FY25 Revenues INR 156.46 crore, up 58% YoY; up 65 % QoQ* EBITDA for 9MFY25 INR 80.78 crore, up183 % YoY* "Significant YoY and QoQ increase in revenue and EBITDA was on the back of volume and price ...

Kite, a Gilead Sciences company, will share four posters that add to the growing body of evidence to support the clinical use of its chimeric antigen receptor (CAR) T-cell therapy portfolio, at the ...

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer ...

Hotels, the nature-inspired luxury lifestyle hotel brand founded by hospitality visionary Barry Sternlicht, is thrilled to ...

Highlight key sector achievementsBy Henry OjeluLagos, February 13, 2025 – The Minister of Marine and Blue Economy, Adegboyega ...

At closing of the transaction, JASMIN shall acquire Pierre Fabre's R&D Centre (including R&D Site and R&D activities) at Saint-Julien-en-Genevois, France, and JBIRSPL would also execute a Shareholders ...

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase ...

Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today's call is being recorded. It is now my pleasure to introduce Matthew Abenante of ...